- Home
- MLYS vs PLXS Comparison
MLYS vs PLXS Comparison
Compare MLYS & PLXS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MLYS
- PLXS
- Stock Information
- Founded
- MLYS 2019
- PLXS 1979
- Country
- MLYS United States
- PLXS United States
- Employees
- MLYS N/A
- PLXS N/A
- Industry
- MLYS Biotechnology: Pharmaceutical Preparations
- PLXS Electrical Products
- Sector
- MLYS Health Care
- PLXS Technology
- Exchange
- MLYS Nasdaq
- PLXS Nasdaq
- Market Cap
- MLYS 3.1B
- PLXS 3.7B
- IPO Year
- MLYS 2023
- PLXS 1986
- Fundamental
- Price
- MLYS $38.06
- PLXS $145.16
- Analyst Decision
- MLYS Strong Buy
- PLXS Strong Buy
- Analyst Count
- MLYS 6
- PLXS 5
- Target Price
- MLYS $42.60
- PLXS $155.75
- AVG Volume (30 Days)
- MLYS 1.6M
- PLXS 214.4K
- Earning Date
- MLYS 11-10-2025
- PLXS 10-22-2025
- Dividend Yield
- MLYS N/A
- PLXS N/A
- EPS Growth
- MLYS N/A
- PLXS 47.80
- EPS
- MLYS N/A
- PLXS 5.87
- Revenue
- MLYS N/A
- PLXS $4,025,169,000.00
- Revenue This Year
- MLYS N/A
- PLXS $3.54
- Revenue Next Year
- MLYS N/A
- PLXS $8.27
- P/E Ratio
- MLYS N/A
- PLXS $24.73
- Revenue Growth
- MLYS N/A
- PLXS 2.31
- 52 Week Low
- MLYS $8.24
- PLXS $103.43
- 52 Week High
- MLYS $41.09
- PLXS $172.89
- Technical
- Relative Strength Index (RSI)
- MLYS 62.11
- PLXS 59.66
- Support Level
- MLYS $37.32
- PLXS $142.70
- Resistance Level
- MLYS $40.51
- PLXS $147.06
- Average True Range (ATR)
- MLYS 2.09
- PLXS 3.41
- MACD
- MLYS -0.77
- PLXS 0.22
- Stochastic Oscillator
- MLYS 43.86
- PLXS 70.29
About MLYS Mineralys Therapeutics Inc.
Mineralys Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing medicines to target diseases driven by abnormally elevated aldosterone. The company's product candidate, lorundrostat, is a proprietary, orally administered, selective aldosterone synthase inhibitor, that is initially developed for the treatment of patients with uncontrolled hypertension, defined as individuals who are unable to achieve BP of below 130/80 mmHg despite taking two or more lines of antihypertensive medication or resistant hypertension, typically including a diuretic.
About PLXS Plexus Corp.
Plexus Corp is a U.S based Electronic Manufacturing Services company that provides a range of services, from conceptualization and design to fulfilling orders and providing sustaining solutions, such as replenishment and refurbishment. The company's segments comprise AMER, APAC,ge and EMEA.